The Commission welcomes today’s political agreement between the European Parliament and the Council on a stronger mandate which establishes a new EU Drugs Agency. The new Agency builds on the achievements of the European Monitoring Centre for Drugs and Drug Addiction
Bibliography: International Policy Issues
Global reviews of injecting drug use highlight inadequate coverage of interventions for people who use drugs
Lead researcher, NDARC’s Scientia Professor Louisa Degenhardt said the landscape has changed since the last review, including increased support for research across multiple low-income and middle-income countries, shifts in patterns of drug use, the development of targets for reductions in HIV and viral hepatitis infection, and the inclusion of drug dependence treatment as one of the United Nations Sustainable Development Goals (NDARC)
Wastewater samples from over 100 European cities reveal latest drug-taking trends
The latest findings from the largest European project in the science of wastewater analysis are released today in Wastewater analysis and drugs — a European multi-city study (EMCDDA)
Global Report on Cocaine 2023
UNODC
The death penalty for drug offences: global overview 2022
This report, our twelfth on the subject, continues our work of providing regular updates on legislative, policy and practical developments related to the use of capital punishment for drug offences, a practice which is a clear violation of international standards (Harm Reduction International)
Global launch of the Annual Report 2022
INCB
Monitoring Data Report 2022
Together with more than one hundred organizations and individuals from thirty-four European countries, C-EHRN set up for itself the task to provide an in-depth look at Harm Reduction in Europe – download report
New EMCDDA work programme prepares agency for significant changes ahead
the latest EMCDDA work programme, which outlines our activities for 2023–2025
Members of the European Parliament endorse a broader mandate for the EMCDDA
Members of the European Parliament (MEPs) from the Civil Liberties Committee (LIBE) adopted a report creating the European Union Drugs Agency and endowing it with new competences (EMCDDA)
Results and challenges of running the Web Survey on Drugs in Luxembourg: a major contribution to understanding the drug situation
This paper shows how the second wave of the European Web Survey on Drugs (EWSD) led to a better understanding of the drug situation in Luxembourg. Until the EWSD, detailed information on the drug situation in Luxembourg was very limited, with only a few surveys, often small-scale, having been conducted in the country since the late 1990s (EMCDDA)
Global State of Harm Reduction
Now in its the eighth edition, the Global State of Harm Reduction 2022 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis Full report Summary (Harm Reduction International)
A Holistic Approach Towards International Counternarcotics Cooperation
We recently traveled together to Colombia to discuss the Biden-Harris administration’s holistic approach to counternarcotics with the newly elected Colombian government, which is informing how we address the production and trafficking of illicit drugs in our own hemisphere and around the globe (The SAIS Review of International Affairs)
European Drug Report 2022: Trends and Developments
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions (EMCDDA)
Mapping prevention systems in the European Neighbourhood Policy area: a baseline for future monitoring and responses
This briefing describes the rationale and methodology of the prevention system mapping, presenting selected findings and highlighting key challenges encountered (EMCDDA)
World Drug Report 2022
Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability (UNODC)
European Drug Report 2022: Trends and Developments
European Drug Report 2022: Trends and Developments (EMCDDA)
European Drug Report 2022: Trends and Developments
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions (EMCDDA)
EU Drugs Agency: Council adopts negotiating mandate on strengthening the role of the agency
To step up the fight against illegal drugs, the Council today adopted its negotiating mandate on the proposal on the EU Drugs Agency, meant to turn the existing European Monitoring Centre for Drugs and Drug Addiction into a fully fledged agency and strengthen its role
Civil society monitoring of harm reduction in Europe 2021 data report
This is the third and last civil society-led C-EHRN Monitoring Report which is produced within the framework of the Operating Grant of the EU Health Programme1 (2018-2021). It is time to stand still and look at what we have achieved so far, what still needs to be done and where we see room for improvement (Correlation – European Harm Reduction Network)
High societies: International experiences of cannabis liberalisation
Across the world, approaches to cannabis regulation are changing. This report reviews evidence from jurisdictions that have liberalised cannabis, assessing how they have impacted health, crime, and economic outcomes, comparing them against the UK’s prohibition regime (Social Market Foundation)
- 1
- 2
- 3
- …
- 15
- Next Page »
